Quick Answer
FATE THERAPEUTICS INC reported Long-Term Debt of $12.45 million for fiscal year 2018.
FATE THERAPEUTICS INC Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2018 | $12.45M | -16.0% |
| 2017 | $14.81M | +492.1% |
| 2016 | $2.50M | -76.6% |
| 2015 | $10.69M | -40.9% |
| 2014 | $18.07M | +943.5% |
| 2012 | $1.73M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| June 30, 2019 | $9.47M | -26.2% | -13.6% |
| March 31, 2019 | $10.96M | -22.1% | -12.0% |
| December 31, 2018 | $12.45M | -16.0% | +7.3% |
| September 30, 2018 | $11.60M | -21.6% | -9.6% |
| June 30, 2018 | $12.84M | +92.3% | -8.8% |
| March 31, 2018 | $14.07M | +1201.5% | -5.0% |
| December 31, 2017 | $14.81M | +492.1% | +0.1% |
| September 30, 2017 | $14.79M | +220.8% | +121.5% |
- FATE THERAPEUTICS INC showed a decrease of -16.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2012–2018 period, FATE THERAPEUTICS INC’s long-term debt has grown by 618.6% (from $1.73 million to $12.45 million).
- The most recent figure is from FATE THERAPEUTICS INC’s fiscal year 2019 report (Form 10-K), filed with the SEC on March 2, 2020.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: